Combined radio-immunotherapy leads to complete clinical regression of stage IV Merkel cell carcinoma

Merkel cell carcinoma (MCC) is a rare, aggressive neuroendocrine tumour of the skin. While localised disease carries an overall favourable prognosis, metastatic disease is associated with poor clincal outcomes. Most cases of metastatic MCC are managed with systemic chemotherapy or immunotherapy, tho...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:BMJ Case Rep
Huvudupphovsmän: Principe, Daniel R, Clark, Joseph I, Emami, Bahman, Borowicz, Stanley
Materialtyp: Artigo
Språk:Inglês
Publicerad: BMJ Publishing Group 2019
Ämnen:
Novel Treatment (New Drug/Intervention; Established Drug/Procedure in New Situation)
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6720814/
https://ncbi.nlm.nih.gov/pubmed/31439556
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2019-230518
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk